• Info
  • Significant Ownership

Significant Ownership of Newpath Partners, L.P.

Signature - Title
By: Newpath Partners GP, L.P. By: /s/ Thomas Cahill - Thomas Cahill, Managing Member
Location
Andover, MA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Newpath Partners, L.P..

Notify me when Newpath Partners, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Newpath Partners, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PRME Prime Medicine, Inc. Common Stock, par value $0.00001 per share 4.7% $9,769,086 6,105,679 Newpath Partners, L.P. 31 Dec 2024

Schedules 13D/G Reported by Newpath Partners, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.